The value of low-dose intraperitoneal immunoglobulin administration in the treatment of peritoneal dialysis-related peritonitis

Coban E., Özdoğan M., Tuncer M., Bozcuk H. Ş., Ersoy F. F.

JOURNAL OF NEPHROLOGY, cilt.17, sa.3, ss.427-430, 2004 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 17 Sayı: 3
  • Basım Tarihi: 2004
  • Dergi Adı: JOURNAL OF NEPHROLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.427-430
  • Anahtar Kelimeler: peritoneal dialysis, CAPD peritonitis, intraperitoneal immunoglobulin, HOST DEFENSE-MECHANISMS, NEUTROPHIL FUNCTION, PHAGOCYTOSIS, CAVITY, CAPD, FIBRONECTIN, MACROPHAGES, CHILDREN
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Background: Peritonitis is a major complication of continuous ambulatory peritoneal dialysis (CAPD). The value of immunomodulatory therapeutic approaches and, especially, methods aimed at augmenting opsonization in the treatment of peritoneal dialysis (PD)-related peritonitis is unclear. In this study, the effect of intraperitoneal (IP) immunoglobulin (Ig) usage, as an approach for strengthening opsonization, was evaluated in CAPD peritonitis.